Login / Signup

Significance of Circulating Cell-Free DNA Biomarkers in HBeAg-Negative Chronic Hepatitis B Virus Infection and Their Changes after Treatment Initiation.

Nikolaos D KarakousisLampros G ChrysavgisAlkistis PapatheodoridiAigli-Ioanna LegakiPanagiotis LembessisEvangelos CholongitasAntonios ChatzigeorgiouGeorgios Papatheodoridis
Published in: Pathogens (Basel, Switzerland) (2023)
Both circulating levels of cf-DNA and 5-methyl-2'-deoxycytidine might be useful biomarkers in order to monitor liver disease activity and response to antiviral treatment in HBeAg-negative chronic HBV patients, but further studies are essential in order to validate these intriguing findings.
Keyphrases